Arcutis Biotherapeutics ARQT Insider Ownership

NASDAQ ARQT

$28.09 +0.70 (+2.57%)

As of: Nov 11, 2026 · 12:09 PM EST

Insider Holdings by Owner

12.27Mn Shares

Life Sciences Viii, L.P. Frazier8.76Mn71.4%

Bhaskar Chaudhuri867.83K7.1%

Todd Watanabe712.83K5.8%

Advisors Llc Orbimed415.14K3.4%

David W Osborne268.85K2.2%

Other insiders (21)1.24Mn10.1%

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

8.88%

▼-0.014% pp QoQ

Shares Held by Insiders

11.60Mn

filed for Sep 2026

▼-0.15% QoQ

Shares Outstanding

130.52Mn

130,522,000 shares

Direct Holdings

2.48Mn

Indirect: 9.12Mn

Net Open-Market Trades

-90.38K

net sold · -$2.30Mn in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Open-Market Insider Trades

Bought Sold

Latest quarter —

Net over range —

Net-buying quarters —

Insider Ownership Summary

Updated Nov 6, 2026

Over the past year, ARQT insiders sold $15.88 million of stock (593.69K shares) on the open market and bought none.

Arcutis Biotherapeutics' open-market sales in the past 12 months came from 11 insiders; no insider bought.
Masaru Matsuda (EVP, Chief Legal Officer) was ARQT's largest open-market seller in the past 12 months, with $3.44 million of sales (121.27K shares); the latest was on November 4, 2026.
Away from the open market, ARQT insiders received 210.93K shares in stock awards, acquired 259.54K shares through option exercises and conversions and gave away 4.31K shares as gifts over the last 12 months.
Per Business Quant data, Arcutis Biotherapeutics insiders hold 11.59Mn shares in total based on their latest Form 4 filings, or 8.88% of the 130.52Mn shares outstanding; that total is down 0.19% from 11.61Mn shares at the end of Q2 2026 and down 4.37% from 12.12Mn shares at the end of Q3 2025.
Direct holdings account for 2.47Mn shares (21.32%) of ARQT's insider total, and indirect holdings through trusts, partnerships and family members for 9.12Mn shares (78.68%).
Holdings in Arcutis Biotherapeutics stock are reported by 17 insiders, the officers, directors and 10% owners who have filed a Form 4 in the past two years.
Arcutis Biotherapeutics' top three insider holders by shares held are Patrick J. Heron (Director, 8.84Mn shares), Todd Watanabe (Director and officer, 945.96K shares) and Bhaskar Chaudhuri (Director, 917.81K shares).
Patrick J. Heron holds 76.30% of the combined insider position in Arcutis Biotherapeutics.
Over the past 12 months, 15 insiders reported transactions in Arcutis Biotherapeutics stock in 63 Form 4 filings.
Insider figures for ARQT include Form 4 filings through November 4, 2026.

Form 4 Holdings

Insiders Holding ARQT

Insiders 26

Shares held 12.27Mn

Of outstanding 9.40%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Life Sciences Viii, L.P. Frazier	TenPercentOwner	8,764,232	0	8,764,232	71.4%	26 Oct, 2023
2	Bhaskar Chaudhuri	Director	867,826	0	867,826	7.1%	16 Jun, 2025
3	Todd Watanabe	President And Ceo	712,826	0	712,826	5.8%	04 Nov, 2026
4	Advisors Llc Orbimed	TenPercentOwner	0	415,142	415,142	3.4%	28 Jun, 2022
5	David W Osborne	Chief Technical Officer	268,854	0	268,854	2.2%	08 Mar, 2023
6	David Joseph Topper	Chief Financial Officer	182,774	0	182,774	1.5%	03 Apr, 2025
7	Larry Todd Edwards	Svp Chief Commercial Officer	175,178	0	175,178	1.4%	03 Mar, 2026
8	Matthew Richard Moore	Svp And Chief Business Officer	145,505	0	145,505	1.2%	03 May, 2024
9	Patrick Burnett	Evp, Chief Medical Officer	116,649	0	116,649	1.0%	04 Nov, 2026
10	Masaru Matsuda	Evp, Chief Legal Officer	111,289	0	111,289	0.9%	04 Nov, 2026
11	Latha Vairavan	Svp Chief Financial Officer	85,978	0	85,978	0.7%	13 May, 2026
12	Kenneth A. Lock	Chief Commercial Officer	63,429	0	63,429	0.5%	08 Mar, 2023
13	Patricia A. Turney	Svp, Operations	62,862	0	62,862	0.5%	08 Mar, 2023
14	Scott L Burrows	Chief Financial Officer	59,115	0	59,115	0.5%	08 Mar, 2023
15	Howard G. Welgus	Chief Medical Officer	35,207	0	35,207	0.3%	19 Oct, 2026
16	Patrick J Heron	Director	32,213	0	32,213	0.3%	09 Jun, 2026
17	Halley E Gilbert	Director	27,901	0	27,901	0.2%	09 Jun, 2026
18	Keith R Leonard	Director	27,901	0	27,901	0.2%	09 Jun, 2026
19	Neha Krishnamohan	Director	27,901	0	27,901	0.2%	09 Jun, 2026
20	Sue-Jean Lin	Director	27,567	0	27,567	0.2%	17 Jun, 2026
21	Terrie Curran	Director	23,526	0	23,526	0.2%	28 Aug, 2026
22	John W Smither	Chief Financial Officer	11,365	0	11,365	0.1%	15 Feb, 2024
23	Amit Munshi	Director	9,799	0	9,799	0.1%	09 Jun, 2026
24	Christopher Peetz	Director	4,315	0	4,315	0.0%	17 Jul, 2026
25	Joseph L Turner	Director	4,312	0	4,312	0.0%	03 Jun, 2022
26	Robert A Scott	Director	2,819	0	2,819	0.0%	28 Oct, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

982 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
02 Nov, 2026	Patrick Burnett	Evp, Chief Medical Officer	Disposed S	943	$31.86	$30.05K	116,649	Direct
02 Nov, 2026	Todd Watanabe	Director, Officer	Disposed S	4,377	$31.86	$139.47K	712,826	Direct
02 Nov, 2026	Masaru Matsuda	Evp, Chief Legal Officer	Disposed S	1,219	$31.86	$38.84K	111,289	Direct
04 Nov, 2026	Masaru Matsuda	Evp, Chief Legal Officer	Acquired M	40,000	$3.64	$145.60K	151,289	Direct
04 Nov, 2026	Masaru Matsuda	Evp, Chief Legal Officer	Disposed S	40,000	$34.32	$1.37Mn	111,289	Direct
04 Nov, 2026	Masaru Matsuda	Evp, Chief Legal Officer	Disposed M	40,000	$0.00	$0	136,000	Direct
23 Oct, 2026	Robert A Scott	Director	Acquired A	2,819	$0.00	$0	2,819	Direct
23 Oct, 2026	Robert A Scott	Director	Acquired A	20,507	$0.00	$0	20,507	Direct
23 Oct, 2026	Robert A Scott	Director	Acquired A	8,663	$0.00	$0	8,663	Direct
15 Oct, 2026	Howard G. Welgus	Director	Acquired M	822	$6.52	$5.36K	36,663	Direct
15 Oct, 2026	Howard G. Welgus	Director	Acquired M	1,018	$7.51	$7.65K	37,681	Direct
15 Oct, 2026	Howard G. Welgus	Director	Acquired M	2,254	$8.63	$19.45K	39,935	Direct
15 Oct, 2026	Howard G. Welgus	Director	Disposed S	4,728	$26.93	$127.33K	35,207	Direct
15 Oct, 2026	Howard G. Welgus	Director	Disposed M	822	$0.00	$0	5,752	Direct
15 Oct, 2026	Howard G. Welgus	Director	Disposed M	1,018	$0.00	$0	7,126	Direct
15 Oct, 2026	Howard G. Welgus	Director	Disposed M	2,254	$0.00	$0	15,778	Direct
16 Sep, 2026	Masaru Matsuda	Officer	Disposed S	3,674	$25.00	$91.85K	112,508	Direct
15 Sep, 2026	Howard G. Welgus	Director	Acquired M	822	$6.52	$5.36K	37,297	Direct
15 Sep, 2026	Howard G. Welgus	Director	Acquired M	1,019	$7.51	$7.65K	38,316	Direct
15 Sep, 2026	Howard G. Welgus	Director	Acquired M	2,255	$8.63	$19.46K	40,571	Direct

Showing 1 to 20 of 982 transactions